{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Oncology Times: May 2011
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Purpose of Activity
To present registered professional nurses with the latest information about breast cancer risk and treatment options for leiomyosarcoma, chronic myeloid leukemia, and malignant melanoma.Learning Objectives
After completing this continuing education activity you will be able to:
- Outline the evidence presented here about the link between obesity and breast cancer.
- Summarize the latest information about morcellation and leiomyosarcoma.
- Discuss the current status of imatinib use for older patients with chronic myeloid leukemia.
- Plan the management of a patient receiving ipilimumab for metastatic melanoma.
Disclosures
The author and planners have disclosed that they have no financial relationships related to this article.
Price:
$24.95
Credits:
- ANCC 2.9 CH
- DC - BON 2.9 CH
- KY-BON 2.9 CH
Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.--------------------------------------------------This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia and Florida #50-1223. Your certificate is valid in all states.--------------------------------------------------The ANCC's accreditation status of Lippincott Williams & Wilkins Department of Continuing Education refers only to its continuing nursing educational activities and does not imply Commission on Accreditation approval or endorsement of any commercial product.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: OT0511
Published: May 10 2011
Expires: 12/31/2026
Sources:
Oncology Times
Required Passing Score: 12/16 (75%)
Specialties:
Oncology